This study is not yet accepting patients
Immunomodulation Using VB-201 to Reduce Arterial Inflammation in Treated HIV - VITAL HIV Trial
Summary
- Eligibility
- for people ages 40-75 (full criteria)
- Location
- at San Francisco, California
- Dates
- study startedestimated completion
- Principal Investigator
- by Priscilla Hsue, MD
Description
Summary
Keywords
Eligibility
Location
Lead Scientist at UCSF
- Priscilla Hsue, MD
Professional Experience: Dr. Hsue trained in Internal Medicine in the Molecular Medicine Training Program at UC San Francisco and in Cardiovascular Medicine at UC San Francisco. She served as Chief Cardiology Fellow during this time. She has been on the faculty in the Department of Medicine at San Francisco General Hospital since 2002.
Details
- Status
- not yet accepting patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Priscilla Hsue, MD
- ID
- NCT04939311
- Phase
- Phase 1/2 research study
- Study Type
- Interventional
- Last Updated